Metraipolis › archive › dc_6335bd3484f2
Complete pathological response with pembrolizumab in recurrent sigmoid adenocarcinoma — Europe PMC PMID:41868703
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41868703
- DOI
- 10.1093/jscr/rjag168
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T03:33:21.839Z
- SHA-256 of the archived text
f4f53799138b2755359d9c22955d0038fb9bab50c3dcd2db9c069a9d7412f60f- Stable URL of this page
https://metraipolis.com/documento/dc_6335bd3484f2
How to cite
Complete pathological response with pembrolizumab in recurrent sigmoid adenocarcinoma — Europe PMC PMID:41868703 — Europe PMC (en), https://europepmc.org/article/MED/41868703 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6335bd3484f2 (Metraipolis archive dc_6335bd3484f2, sha256 f4f53799138b2755359d9c22955d0038fb9bab50c3dcd2db9c069a9d7412f60f)
BibTeX
@misc{dc6335bd3484f2,
title = {Complete pathological response with pembrolizumab in recurrent sigmoid adenocarcinoma — Europe PMC PMID:41868703},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41868703},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6335bd3484f2; sha256 f4f53799138b2755359d9c22955d0038fb9bab50c3dcd2db9c069a9d7412f60f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41868703. Agents can read the archived copy with the MCP tool read_document.